Compare AHH & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHH | CTKB |
|---|---|---|
| Founded | 1979 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.8M | 433.8M |
| IPO Year | 2013 | 2021 |
| Metric | AHH | CTKB |
|---|---|---|
| Price | $6.77 | $4.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.13 | $5.88 |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 12.15% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $452,636,000.00 | $196,828,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.68 | $5.62 |
| P/E Ratio | $35.75 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.01 | $2.37 |
| 52 Week High | $10.55 | $7.30 |
| Indicator | AHH | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 53.77 | 49.85 |
| Support Level | $6.90 | $4.56 |
| Resistance Level | $7.13 | $4.95 |
| Average True Range (ATR) | 0.15 | 0.24 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 48.94 | 38.83 |
Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.